Quantcast

Latest Zeneca Stories

2014-07-02 08:24:16

LONDON, July 2, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: AstraZeneca PLC - Product Pipeline Review - 2014 http://www.reportbuyer.com/computing_electronics/manufacturing/astrazeneca_plc_product_pipeline_review_2013.html AstraZeneca PLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'AstraZeneca PLC - Product Pipeline Review - 2014', provides an overview of the AstraZeneca PLC's pharmaceutical research and development focus....

2014-06-17 12:29:08

Selected academic researchers to receive access to AstraZeneca's compound library to aid in the discovery of new medicines BALTIMORE, June 17, 2014 /PRNewswire-USNewswire/ -- The Academic Drug Discovery Consortium (ADDC) announced today a collaboration between ADDC and AstraZeneca aimed at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application. More specifically, the goal of this...

2014-06-17 12:22:45

CARY, N.C., June 17, 2014 /PRNewswire/ -- Summit Agro USA (SAUS) announces the appointment of William (Bill) M. Lewis to the position of President and CEO. Mr. Lewis is replacing Bill Wisdom, who retired at the end of March. Mr. Lewis has extensive agricultural chemical industry experience having held numerous management positions with ICI, Zeneca, Syngenta and Arysta over the past 28 years. In the past two years, Mr. Lewis has owned and operated two John Deere dealerships in the...

2014-05-27 16:25:33

DUBLIN, May 27, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Saxagliptin Hydrochloride Tablets, 2.5 mg and 5 mg. Actavis' ANDA product is a generic version of AstraZeneca and Bristol-Myers Squibb's Onglyza(®), which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes....

2014-03-28 12:26:18

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8pl45q/investigation) has announced the addition of the "Investigation Report on China Quetiapine Market, 2009-2018" [http://www.researchandmarkets.com/research/8pl45q/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can...

2014-03-28 12:26:09

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/lj5htc/investigation) has announced the addition of the "Investigation Report on China's Esomeprazole Market, 2009-2018" [http://www.researchandmarkets.com/research/lj5htc/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Digestive system disease is one of the most frequently occurring diseases....

2014-03-25 00:21:44

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the "Investigation Report on China Budesonide Market" [http://www.researchandmarkets.com/research/s3kv36/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Asthma and allergic rhinitis are both very common diseases in the world today. As the global atmosphere...

2014-02-20 16:21:25

Agreement with Biopharmaceutical Leader is Indicative of the Longstanding Value of CAS Products COLUMBUS, Ohio, Feb. 20, 2014 /PRNewswire/ -- Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today a landmark five-year agreement for SciFinder(®), the choice for chemistry research, with AstraZeneca, a leading biopharmaceutical company specializing in the discovery, development, manufacturing and marketing of prescription medicines. The...

2014-02-05 08:30:28

SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- Ambrx Inc. today announced the appointment of Barry Greene to its board of directors. Mr. Greene has more than 20 years of experience in the healthcare, pharmaceutical and biotechnology industries. He is currently president and chief operating officer of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), a leader in RNAi therapeutics. The appointment increases Ambrx's board membership to six. "Barry joins Ambrx's board at a very exciting time for...

2014-01-21 23:27:11

“2014 Deep Research Report on Global and China Propofol Industry” and “2014 Deep Research Report on Global And China Nucleotide Industry” are the new research reports added to the online library of DeepResearchReports.com. Dallas, Texas (PRWEB) January 21, 2014 2014 Deep Research Report on Global And China Nucleotide Industry is a professional and in-depth study on the current state of the nucleotide industry in Global and China. The report provides a basic overview of the...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related